BRIEF-Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing

Summit Therapeutics

Summit Therapeutics

SMMT

0.00

June 11 (Reuters) - Summit Therapeutics Inc SMMT.O:

  • SUMMIT THERAPEUTICS - WITHDRAWS PROPOSED UNDERWRITTEN PUBLIC OFFERING EFFECTIVE JUNE 10, 2026 - SEC FILING

  • SUMMIT THERAPEUTICS - NO SECURITIES TO BE SOLD IN PROPOSED UNDERWRITTEN PUBLIC OFFERING - SEC FILING

Source text: [ID:n0001599298-26-000052]

Further company coverage: SMMT.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.